Literature DB >> 14600148

Cells previously desensitized to type 1 interferons display different mechanisms of activation of stat-dependent gene expression from naïve cells.

Shuji Sakamoto1, Jinzhong Qin, Angels Navarro, Ana Gamero, Ramesh Potla, Taolin Yi, Wei Zhu, Darren P Baker, Gerald Feldman, Andrew C Larner.   

Abstract

Over the past decade, a wealth of knowledge has been obtained concerning the mechanisms by which interferons (IFNs) and other cytokines activate or down-regulate immediate early genes via the Jak/Stat pathway. In contrast, little information is available on interferon-activated gene expression in naïve cells compared with cells that have been desensitized and subsequently resensitized to the actions of these cytokines. In naïve cells, the ISG54 gene is activated via IFN beta-stimulated formation of ISGF3, a heterotrimeric DNA binding complex consisting of p48 (IRF9) and tyrosine-phosphorylated Stat1 and Stat2. In contrast, in previously desensitized cells IFN beta weakly stimulates the assembly of an ISGF3-like complex that lacks Stat1, even though ISG54 mRNA induction is the same as in naïve cells. The lack of Stat1 tyrosine phosphorylation and DNA binding is due to increased activity of a protein-tyrosine phosphatase. In cells that do not express the tyrosine phosphatase Tc-PTP, the rate of Stat1 dephosphorylation is the same in naïve and previously desensitized cells. These results implicate Tc-PTP in a novel role in the regulation of type 1 interferon-stimulated gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600148     DOI: 10.1074/jbc.M309631200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms.

Authors:  Ana M Gamero; Ramesh Potla; Shuji Sakamoto; Darren P Baker; Robert Abraham; Andrew C Larner
Journal:  Cell Signal       Date:  2005-12-06       Impact factor: 4.315

2.  Homeostatic interferon expression in neurons is sufficient for early control of viral infection.

Authors:  Sarah E Cavanaugh; Alicia M Holmgren; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2014-12-16       Impact factor: 3.478

3.  A phosphorylation-acetylation switch regulates STAT1 signaling.

Authors:  Oliver H Krämer; Shirley K Knauer; Georg Greiner; Enrico Jandt; Sigrid Reichardt; Karl-Heinz Gührs; Roland H Stauber; Frank D Böhmer; Thorsten Heinzel
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

4.  Identification of STAT2 serine 287 as a novel regulatory phosphorylation site in type I interferon-induced cellular responses.

Authors:  Håkan C Steen; Shoko Nogusa; Roshan J Thapa; Suresh H Basagoudanavar; Amanda L Gill; Salim Merali; Carlos A Barrero; Siddharth Balachandran; Ana M Gamero
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

Review 5.  IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research.

Authors:  Bing Liu; Ian McGilvray; Limin Chen
Journal:  Gastroenterol Res Pract       Date:  2015-05-20       Impact factor: 2.260

6.  Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Authors:  Alain Calender; Pierre Antoine Rollat Farnier; Adrien Buisson; Stéphane Pinson; Abderrazzaq Bentaher; Serge Lebecque; Harriet Corvol; Rola Abou Taam; Véronique Houdouin; Claire Bardel; Pascal Roy; Gilles Devouassoux; Vincent Cottin; Pascal Seve; Jean-François Bernaudin; Clarice X Lim; Thomas Weichhart; Dominique Valeyre; Yves Pacheco; Annick Clement; Nadia Nathan
Journal:  BMC Med Genomics       Date:  2018-03-06       Impact factor: 3.063

7.  Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation.

Authors:  Eirini Kalliara; Malgorzata Kardynska; James Bagnall; David G Spiller; Werner Müller; Dominik Ruckerl; Jarosław Śmieja; Subhra K Biswas; Pawel Paszek
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

8.  IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.

Authors:  Stephen G Maher; Faruk Sheikh; Anthony J Scarzello; Ana L Romero-Weaver; Darren P Baker; Raymond P Donnelly; Ana M Gamero
Journal:  Cancer Biol Ther       Date:  2008-04-24       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.